# Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs

> **NCT02641899** · PHASE1 · COMPLETED · sponsor: **Intarcia Therapeutics** · enrollment: 33 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ITCA 650 20/60 mcg/day
- **DRUG:** Acetaminophen
- **DRUG:** Atorvastatin
- **DRUG:** Lisinopril
- **DRUG:** Warfarin
- **DRUG:** Digoxin

## Key facts

- **NCT ID:** NCT02641899
- **Lead sponsor:** Intarcia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02641899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02641899, "Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02641899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*